'The last big guy' | Kill the medical equipment circle, the wolf ?!

Medical Network February 24 hearing the surge in medical device market, the capital from time to time to spoil the Council, but not have to retreat.

Into 2018, in the medical device industry, there is an event that people can not ignore: the lakes gang eldest brother gold came out, aimed at actually medical equipment circle.

On February 12, Kelite announced that Yongjin Investment Holdings Co., Ltd. ("Yongjin Investment") intends to transfer 50.1 million Kellett shares for a total amount of 446 million yuan, accounting for 7% of Kelly's total share capital.

Prior to this transaction, Ding Liang Yixiang and Shen Jing, acting in concert with Yongjin Investment, respectively held 2.08% and 0.66% equity interests in Kellett Thailand After the completion of the transaction, Yongjin Investment and the Undertaker (Yongjin Department) Will hold a total of 9.74% stake in Keli Tai, Kelly became the largest shareholder.

Yongding is a big legend of rivers and lakes, from the 90s of last century to the beginning of this century, through a series of complex unpredictable capital operation, to establish a huge capital empire and become the actual controller of a series of listed companies.

The rise of the Department of gold, medicine The industry can not be opened up, and the "medicine + finance" is its unique way of capital operation. Yongjin Holdings holds the Jiuzhitang, a listed company, and relies on it to build an M & A platform. Major shareholder, and participated in the investment of 39 medicine.

As representatives of the "family-run family business", after the defeat of the Delong, Hong Yi, North Korea and Success Stages, the Yong Family still maintained its strong momentum of development.

However, there are unexpected events in 2008. In 2008, the founder Wei Dong jumped to death, Yong Department of gold began to gradually lose in the capital markets, the financial empire gradually disintegrated, and even voices called 'the last big guy' has been lonely curtain call.

In the post-Wei era, the Yongjin system sold off the Jiuzhitang and Qianjin Pharmaceuticals shares one after another in 2015, losing control of the Jiuzhitang, which is seen as shifting from the strategy of "medicine + finance" to the direction of pure finance.

However, a sudden increase in capital Kelly, becoming the largest shareholder, control, seems to announce another signal, Chungking Department to kill the medical circle, and this aiming is not drug Industry, but medical instruments industry.

In fact, Chung Wo's investment in Shanghai Cheung Wo as early as 2009 has been involved Kelly (2013 has been withdrawn), Kelly listed as the lead underwriter is another gold medal in the Department of the other countries - the country Gold Securities.

After Kelitail went public in 2012, it planned more than one round of mergers and acquisitions and set increases, among which there was also a gold medal.

In early 2015, Kelly also decided to set up a merger fund with another war company under Yongking, such as Yunnan Trust, which completed the filing last year.

Yong Department of gold and Keli Tai, can be described as profound origin.

In the medical circle, Shanghai Derigen has the title of "Chinese version of Medtronic," but like Merrill Lynch like Merger and Acquisition of Keli Tai.

Kelitai in June 2012 after the listing and financing, investment, mergers and acquisitions continue to sprinkle money over 1 billion yuan:

A wholly-owned subsidiary of Beijing Easy Science and Technology, won the coronary stent drug product line, but also the business extends to the field of cardiovascular intervention;

A wholly owned acquisition of Jiangsu Aidir, into the field of orthopedic trauma products;

Took 25% stake in Tianjin Jingwei Medical, extending its business to the field of orthopedic joint products;

Through Easy Technology, intends to wholly-owned acquisition of Ningbo Shen Cebo Bo, which is home medical equipment circulation;

Involved in investing in the new three board listed companies Yong Ming Medicine, which is home CRO suppliers for cardiovascular equipment manufacturers to provide clinical trial services;

Scored 10% stake in Jiaxing Bo set, which is the home orthopedic mobile medical products suppliers;

Equity joint venture set up Shanghai Yiu Thai Medical Technology Co., Ltd., which is a joint venture enterprise , Kelly shares 51% of shares, Italy orthopedic equipment company TECRES S.P.A shares 49%.

Kellett Thai vertebral body formed by the product, and then rapidly expanded through mergers and acquisitions, the product has been extended to the entire field of orthopedics, also occupy a place in the cardiovascular field.

M & A also brought rapid revenue growth.From January to September 2017, Kellytai revenue 572 million yuan, an increase of 37.56%, net profit of 151 million, an increase of 24.08% from the data, in recent years, Kelly The revenue and net profit growth have exceeded the industry average.

However, Kaili Tai is bigger, the industry rivals are also growing.Its supplies in the field, the changes in recent years are not small, engage in mergers and acquisitions, the market, the introduction of overseas technology ...... Market competition is growing.

Yong Jin Department of the main IPO has been Kelly, apparently not listed for the money, what?

Kellett's position as a strategic investor in Yongking's investment is "strategic investor." Yongjing Investment said that as the largest shareholder, it will actively participate in the governance of listed companies, improve their asset and liability structure, optimize their business structure and enhance their asset quality , Profitability and cash flow status.

Yongjin Investment also said that in the next 12 months, the listed companies or subsidiaries of assets and businesses for sale, mergers, joint ventures or cooperation with others, or listed companies to purchase or replacement of assets with the implementation of the restructuring plan .

Yong Jin Department of Industry to do, it seems not credible.

From the Yong family, from the past, Kaili Tai will become another Jiuzhitang, has also been created as a super industry M & A platform ?!

Even more, Kellett Thailand mergers and acquisitions a lot, but all with the medical device industry, associated with its main business. Yong family after the invasion, Kellett Thai will open another path of mergers and acquisitions, the tentacles stretched orthopedic, cardiovascular supplies Outside the field or even beyond the medical device industry?